Patent Applications published on Apr 25, 2024 - page 3

#601
US20240130861A1
Human necessities

BONE IMPLANT SYSTEM, BONE IMPLANT, AND METHOD FOR PRODUCING SUCH A BONE IMPLANT

#602
US20240130862A1
Human necessities

IMPLANT STEM WITH SUTURE RETENTION STRUCTURE

#603 ✅ Patent 12,121,449 granted on 2024-10-22
US20240130863A1
Human necessities

Systems and methods for knee arthroplasty

#604
US20240130864A1
Human necessities

IMPLANTS, SYSTEMS AND METHODS OF USING THE SAME

#605
US20240130865A1
Human necessities

EXPANDABLE IMPLANT ASSEMBLY

#606
US20240130866A1
Human necessities

COMPOUND-ARC, SPLINED ANCHOR

#607
US20240130867A1
Human necessities

SPINAL IMPLANT SYSTEM AND METHODS OF USE

#608
US20240130868A1
Human necessities

IN-SITU ADDITIVE EXPANDABLE IMPLANTS

#609
US20240130869A1
Human necessities

GRAFT DEPLOYMENT SYSTEMS AND METHODS

#610
US20240130870A1
Human necessities

SYSTEMS AND METHODS FOR APPROXIMATING MUSCULOSKELETAL DYNAMICS

#611
US20240130871A1
Human necessities

DRUG-COATED ENDOVASCULAR DEVICES

#612
US20240130872A1
Human necessities

STENT SYSTEM FOR MAINTAINING PATENCY OF A BODY LUMEN

#613
US20240130873A1
Human necessities

ADJUSTABLE MANDREL FOR FORMING STENT WITH ANTI-MIGRATION FEATURES

#614
US20240130874A1
Human necessities

DEVICES, SYSTEMS, AND METHODS FOR DELIVERING A STENT

#615 ✅ Patent 12,213,899 granted on 2025-02-04
US20240130875A1
Human necessities

Stent

#616
US20240130876A1
Human necessities

INTRAVASCULAR STENT HAVING HIGH FATIGUE PERFORMANCE

#617
US20240130877A1
Human necessities

MULTI-COMPONENT DELIVERY SYSTEMS AND METHODS

#618
US20240130878A1
Human necessities

PROXIMAL STENT-GRAFT RETENTION SYSTEM

#619
US20240130879A1
Human necessities

AUTOMATED RETRIEVABLE HEMORRHAGE CONTROL SYSTEM

#620
US20240130880A1
Human necessities

Implant DELIVERY SYSTEM AND METHOD OF USE

#621
US20240130881A1
Human necessities

ANKLE FOOT ORTHOSIS

#622
US20240130882A1
Human necessities

INTELLIGENT ORTHOPEDIC DEVICE SYSTEM, AND METHOD OF USING THE SAME

#623
US20240130883A1
Human necessities

INFLATABLE ANKLE BRACE

#624 ✅ Patent 12,290,462 granted on 2025-05-06
US20240130884A1
Human necessities

Anatomical brace for dynamically stabilizing the elbow

#625
US20240130885A1
Human necessities

PORTABLE FLUID COLLECTION PAD FOR USE WITH FLUID COLLECTION SYSTEMS AND RELATED METHODS

#626
US20240130886A1
Human necessities

IMPROVED OSTOMY APPLIANCE

#627 ✅ Patent 12,042,420 granted on 2024-07-23
US20240130887A1
Human necessities

Urine collection bag assembly

#628
US20240130888A1
Human necessities

Female Universal Condom Device

#629
US20240130889A1
Human necessities

ARTICLES TO MANIPULATE THE TEMPERATURE OF BODY EXTREMITIES

#630
US20240130890A1
Human necessities

SUSTAINED-RELEASE IMPLANTS FOR LOWERING INTRAOCULAR PRESSURE WITH EXTENDED DURATION OF EFFECT

#631
US20240130891A1
Human necessities

METHOD AND SYSTEM FOR CATARACT REMOVAL

#632
US20240130892A1
Human necessities

NOVEL AQUEOUS HUMOR DRAINAGE DEVICE FOR CONTROLLING INTRAOCULAR PRESSURE

#633
US20240130893A1
Human necessities

OPHTHALMOLOGICAL LASER DEVICE

#634 ✅ Patent 12,053,419 granted on 2024-08-06
US20240130894A1
Human necessities

Eye mask with movable speakers

#635
US20240130895A1
Human necessities

HEARING PROTECTION DEVICES

#636
US20240130896A1
Human necessities

ADVANCED COCHLEA ACCESS

#637
US20240130897A1
Human necessities

WOUND DRESSING SYSTEMS AND METHODS OF USE

#638
US20240130898A1
Human necessities

WOUND THERAPY SYSTEM AND WOUND DRESSING WITH PH SENSOR

#639
US20240130899A1
Human necessities

NONWOVEN FABRICS

#640
US20240130900A1
Human necessities

METHOD AND APPARATUS FOR PRODUCING ABSORBENT SANITARY ARTICLES

#641
US20240130901A1
Human necessities

FEMININE HYGIENE ARTICLES AND FILM WITH IMPROVED SOFTNESS AND HAND FEEL

#642
US20240130902A1
Human necessities

WEARABLE ARTICLE COMPRISING A LAMINATE

#643
US20240130903A1
Human necessities

COMPOSITE ABSORBER, AND POLYMER ABSORBENT

#644
US20240130904A1
Human necessities

MULTI-LAYERED ABSORBENT MATERIAL

#645
US20240130905A1
Human necessities

ABSORBENT SUBSTRATES WITH HIGH PERCENTAGES OF SUPERABSORBENT MATERIAL AND METHODS OF FORMING THE SAME

#646
US20240130906A1
Human necessities

Patient Transport Apparatus With Steer Lock Assembly

#647
US20240130907A1
Human necessities

WHEELCHAIR FIXING DEVICE AND WHEELCHAIR FIXING SYSTEM

#648
US20240130908A1
Human necessities

Portable wheelchair propelling device powered by patients' arm (or arms) pulling on handles instead of turning the wheels

#649
US20240130909A1
Human necessities

APPARATUS COMPRISING AN INCLINE BED AND METHOD FOR TREATING SYMPTOMS OF PATIENTS WITH CHRONIC DISORDERS

#650
US20240130910A1
Human necessities

ELECTRIC FURNITURE

#651
US20240130911A1
Human necessities

Portable Patient Lift

#652
US20240130912A1
Human necessities

Hyperbaric Chamber with Therapeutic Pressure Control

#653
US20240130913A1
Human necessities

Device Holder for Inversion Table

#654 ✅ Patent 12,370,110 granted on 2025-07-29
US20240130914A1
Human necessities

DYNAMIC HEADSET APPARATUS

#655
US20240130915A1
Human necessities

DEVICE WITH THERAPEUTIC FEATURES

#656 ✅ Patent 12,310,906 granted on 2025-05-27
US20240130916A1
Human necessities

Adjustable cervical traction assemblies for person support apparatuses

#657 ✅ Patent 12,178,772 granted on 2024-12-31
US20240130917A1
Human necessities

Differential air pressure systems and methods of using and calibrating such systems for mobility impaired users

#658
US20240130918A1
Human necessities

EXERCISE APPARATUS FOR HELPING GROWTH THROUGH STRETCHING AND STIMULATION OF KNEE JOINT AREA

#659
US20240130919A1
Human necessities

SYSTEM FOR GAIT TRAINING

#660
US20240130920A1
Human necessities

INDOOR ROLLATOR WITH RISE-UP STRUCTURE

#661 ✅ Patent 12,127,998 granted on 2024-10-29
US20240130921A1
Human necessities

Sensor based clear path robot guide

#662
US20240130922A1
Human necessities

HAPTIC GUIDING SYSTEM

#663
US20240130923A1
Human necessities

ADAPTIVE SEAT MASSAGE SYSTEM AND METHOD OF CONTROLLING THE SAME

#664
US20240130924A1
Human necessities

METHOD OF APPLYING WAVE THERAPY AND AN OCCUPANT PLATFORM FOR USE WITH SAME

#665
US20240130925A1
Human necessities

WEARABLE HEALTH MANAGEMENT SYSTEM

#666
US20240130926A1
Human necessities

MUSCLE FITNESS RELAXATION DEVICE

#667
US20240130927A1
Human necessities

SYSTEM FOR ELECTRICAL CONNECTION OF MASSAGE ATTACHMENT TO PERCUSSIVE THERAPY DEVICE

#668
US20240130928A1
Human necessities

MANIPULATOR FOR A MASSAGE DEVICE

#669 ✅ Patent 12,220,379 granted on 2025-02-11
US20240130929A1
Human necessities

Low EMF halogen tube heater

#670
US20240130930A1
Human necessities

Infant Bottle Holding Device

#671
US20240130931A1
Human necessities

ENTERAL FEEDING TUBE WITH POLYGONAL CONFIGURATION

#672
US20240130932A1
Human necessities

CALCIUM SILICATE-BASED HYDRAULIC CEMENT TO FORM A COMPOSITE MATERIAL HAVING REINFORCING PROPERTIES

#673 ✅ Patent 12,337,043 granted on 2025-06-24
US20240130933A1
Human necessities

CURABLE RADIOPAQUE SUBSTANCE

#674
US20240130934A1
Human necessities

BULK BLOCK FOR MANUFACTURING DENTAL PROSTHESIS

#675
US20240130935A1
Human necessities

PROBIOTICS REVITALIZING SYSTEM FOR SKINCARE

#676
US20240130936A1
Human necessities

WATER-IN-SILICONE COMPLEXION EMULSIONS

#677
US20240130937A1
Human necessities

ORAL CARE COMPOSITION

#678
US20240130938A1
Human necessities

A COMPOSITION FOR DEVELOPING HAIR COLOR COMPRISING POLYPHENOL

#679
US20240130939A1
Human necessities

HAIR COSMETIC

#680
US20240130940A1
Human necessities

AN IMPROVED LONG WEARING SUNSCREEN COSMETIC

#681
US20240130941A1
Human necessities

TOPICAL COMPOSITIONS OPTIMISED FOR EPIDERMAL LIPIDS AND PHOSPHATIDYL GYCEROL

#682
US20240130942A1
Human necessities

Composition for Treating Hair and Skin

#683
US20240130943A1
Human necessities

NAIL POLISH GLUE AND PREPARATION METHOD AND APPLICATION THEREOF

#684
US20240130944A1
Human necessities

LRAT INHIBITORS FOR TREATING SKIN AGEING

#685
US20240130945A1
Human necessities

METHODS AND FORMULATIONS FOR MITIGATING DAMAGING EFFECTS FROM EXPOSURE TO UV RADIATION

#686
US20240130946A1
Human necessities

ANTIBACTERIAL SYSTEM WITH NATURALLY DERIVED INGREDIENTS AND COMPOSITIONS COMPRISING THEM

#687
US20240130947A1
Human necessities

TOPICAL COMPOSITION FOR REGULATION OF INFLAMMATION AND SKIN REGENERATION

#688
US20240130948A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING THE APPEARANCE OF THE SKIN

#689
US20240130949A1
Human necessities

COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI

#690
US20240130950A1
Human necessities

LIQUID CRYSTAL COMPOSITION INCLUDING CERAMIDE AND METHOD OF PREPARING THE SAME

#691
US20240130951A1
Human necessities

COATED PARTICLE, METHOD FOR PRODUCING SAME, AND COSMETIC

#692
US20240130952A1
Human necessities

REACTIVE TOPICAL SKIN PROTECTANT FORMULATIONS FOR THE PROTECTION AGAINST SKIN PENETRATION OF LIQUID CHEMICAL AGENTS OR HARMFUL TOXIC SUBSTANCES

#693
US20240130953A1
Human necessities

PRODUCTION PROCESS OF A CONVENIENT AND QUICK-ADHESIVE EYELASHES

#694
US20240130954A1
Human necessities

EMULSIFIED COMPOSITION AND COSMETIC MATERIAL

#695
US20240130955A1
Human necessities

AMINO-MODIFIED SILICONE EMULSION, HAIR COSMETIC, AND FIBER TREATMENT AGENT

#696
US20240130956A1
Human necessities

HAIR COSMETIC COMPOSITION

#697
US20240130957A1
Human necessities

EXTRACTS OF ISOCHRYSIS SPECIES/TISOCHRYSIS SPECIES

#698
US20240130958A1
Human necessities

COSMETIC COMPOSITION COMPRISING BLACK YEAST-DERIVED EXOSOMES

#699
US20240130959A1
Human necessities

CREAM FOR TREATING ACNE AND MELASMA

#700
US20240130960A1
Human necessities

BIOME-FRIENDLY CONSUMER PRODUCTS

#701
US20240130961A1
Human necessities

TRANSMUCOSAL DRUG DELIVERY DEVICES FOR USE IN CHRONIC PAIN RELIEF

#702
US20240130962A1
Human necessities

TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS

#703
US20240130963A1
Human necessities

MEDICAL IMPLANT

#704
US20240130964A1
Human necessities

SOFT CHEWABLE FORMULATIONS WITH ACTIVE INGREDIENTS

#705 ✅ Patent 12,201,721 granted on 2025-01-21
US20240130965A1
Human necessities

Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device

#706
US20240130966A1
Human necessities

INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF

#707 ✅ Patent 12,318,479 granted on 2025-06-03
US20240130967A1
Human necessities

Process of making nanoemulsion

#708
US20240130968A1
Human necessities

METHODS AND PRODUCTS FOR TREATING SUBJECTS WITH AUTISM SPECTRUM DISORDERS

#709
US20240130969A1
Human necessities

LIPID NANOPARTICLES AND METHODS OF USE THEREOF

#710
US20240130970A1
Human necessities

LIQUID-CRYSTAL POLYESTER POWDER AND METHOD FOR PRODUCING LIQUID-CRYSTAL POLYESTER SOLUTION COMPOSITION

#711
US20240130971A1
Human necessities

METHOD FOR THE PRODUCTION OF PRECISELY SIZED MACRO- AND MICRO-ELP CONTAINING PARTICLES FOR THE DELIVERY OF THERAPEUTIC AGENTS

#712
US20240130972A1
Human necessities

FORMULATION OF A MULTI LAYERED PELLET COMPRISING MELATONIN

#713 ✅ Patent 12,303,602 granted on 2025-05-20
US20240130973A1
Human necessities

Compositions, methods and uses for thermally stable multi-targeted antigens

#714
US20240130974A1
Human necessities

SOLID PHARMACEUTICAL TABLET

#715
US20240130975A1
Human necessities

DRUG DELIVERY IN NEGATIVE POISSON`S RATIO STRUCTURES

#716
US20240130976A1
Human necessities

Pharmaceutical Formulation of Odevixibat

#717 ✅ Patent 12,263,251 granted on 2025-04-01
US20240130977A1
Human necessities

Orally available articles containing at least one stabilized supplement therein

#718
US20240130978A1
Human necessities

TTS-FORMULATION WITH THC

#719
US20240130979A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN CONDITIONS

#720 ✅ Patent 12,194,003 granted on 2025-01-14
US20240130980A1
Human necessities

Compositions for treating acne and dermatological conditions

#721
US20240130981A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING A CANNABINOID

#722
US20240130982A1
Human necessities

TREATMENT OF AVASCULAR OR HYPOVASCULAR MICRO-TUMORS

#723 ✅ Patent 12,138,232 granted on 2024-11-12
US20240130983A1
Human necessities

Compounds for treating coronavirus infection

#724
US20240130984A1
Human necessities

AMINONAPHTHOQUINONE COMPOUNDS FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES

#725
US20240130985A1
Human necessities

SOLID PHARMACEUTICAL TABLET

#726
US20240130986A1
Human necessities

A PROPYL PROPANE THIOSULFONATE COMPOUND FOR USE AS ANTITUMORAL

#727
US20240130987A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING 4- HYDROXYPHENYLPYRUVATE DIOXYGENASE-LIKE (HPDL)-RELATED DISEASES OR DISORDERS

#728
US20240130988A1
Human necessities

Use of stilbene compounds in the preparation of anti-tumor drugs

#729
US20240130989A1
Human necessities

STABLE TREPROSTINIL PRODRUGS

#730
US20240130990A1
Human necessities

PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL SOLUTION

#731
US20240130991A1
Human necessities

RUMEN-PROTECTED COMPOSITIONS AND METHODS OF MAKING THE SAME

#732
US20240130992A1
Human necessities

LIQUID FOOD PRODUCT TO MANAGE THE KETOGENIC DIET

#733
US20240130993A1
Human necessities

DHA Enriched Polyunsaturated Fatty Acid Compositions

#734
US20240130994A1
Human necessities

IONIC LIQUID FORMULATIONS FOR TREATING DIABETES

#735
US20240130995A1
Human necessities

NOVEL TREATMENTS

#736
US20240130996A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND PHARMACOKINETICS OF A GAMMA-HYDROXYBUTYRIC ACID DERIVATIVE

#737
US20240130997A1
Human necessities

Compositions for ophthalmic care

#738
US20240130998A1
Human necessities

ANALGESIA FROM ORAL PROCAINE A FORGOTTEN VOLTAGE GATED SODIUM CHANNEL BLOCKER

#739
US20240130999A1
Human necessities

Inhibition of SLC4A4 in the Treatment of Cancer

#740
US20240131000A1
Human necessities

AGENTS AND METHODS FOR PREVENTING AND TREATING SKELETAL MUSCLE DISEASES

#741
US20240131001A1
Human necessities

PHARMACEUTICAL APPLICATION OF FUSED RING PHENOLIC COMPOUNDS

#742 ✅ Patent 12,370,171 granted on 2025-07-29
US20240131002A1
Human necessities

ORAL CANNABINOID PRODUCT WITH LIPID COMPONENT

#743
US20240131003A1
Human necessities

SYSTEMS AND METHODS FOR TREATING CORONAVIRUS

#744
US20240131004A1
Human necessities

FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF INFLAMMATION AND PAIN

#745 ✅ Patent 12,171,745 granted on 2024-12-24
US20240131005A1
Human necessities

Compositions and methods for treating non-hemorrhagic closed head injury

#746
US20240131006A1
Human necessities

ANTI-FIBROTIC THERAPIES

#747
US20240131007A1
Human necessities

METHODS AND COMPOSITIONS FOR PICORNAVIRUS ANTI-VIRAL AGENTS

#748 ✅ Patent 12,213,963 granted on 2025-02-04
US20240131008A1
Human necessities

Topical formulation of disease-modifying antirheumatic drug (DMARDs) for the treatment of rheumatoid arthritis, melanoma, squamous cell carcinoma, atopic dermatitis, and psoriasis

#749
US20240131009A1
Human necessities

PHARMACEUTICAL COMBINATION COMPRISING A SELECTIVE S1P1 RECEPTOR AGONIST

#750
US20240131010A1
Human necessities

SUSTAINED RELEASE OSMOTIC-CONTROLLED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF

#751
US20240131011A1
Human necessities

PYRUVATE KINASE R (PKR) ACTIVATING COMPOSITIONS

#752
US20240131012A1
Human necessities

RAPAMYCIN ANALOGS AND USES THEREOF

#753
US20240131013A1
Human necessities

TETRAHYDRO-1H-PYRIDO[3,4-b]INDOLE ANTI-ESTROGENIC DRUGS

#754
US20240131014A1
Human necessities

ENHANCEMENT OF MICROFRACTURE FOR REPAIRING CARTILAGE DEFECTS VIA WNT INHIBITION

#755
US20240131015A1
Human necessities

MEDICAMENT FOR TREATMENT AND/OR PROPHYLACTIC TREATMENT OF CANCERS

#756
US20240131016A1
Human necessities

IRAK DEGRADERS AND USES THEREOF

#757
US20240131017A1
Human necessities

HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS

#758
US20240131018A1
Human necessities

PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB

#759
US20240131019A1
Human necessities

METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA, FUNGUS, OR VIRUS BY ADMINISTRATION OF TAFENOQUINE

#760 ✅ Patent 12,370,188 granted on 2025-07-29
US20240131020A1
Human necessities

FORMULATIONS OF GLUCOCORTICOID RECEPTOR MODULATORS

#761
US20240131021A1
Human necessities

OPIOID FORMULATIONS

#762
US20240131022A1
Human necessities

OPIOID OVERDOSE REVERSAL MIXTURES

#763
US20240131023A1
Human necessities

COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR

#764
US20240131024A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS

#765 ✅ Patent 12,133,849 granted on 2024-11-05
US20240131025A1
Human necessities

Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha- emitting radioimmunotherapeutic

#766
US20240131026A1
Human necessities

BROMOCRIPTINE FORMULATIONS

#767
US20240131027A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING NOVEL SD911 COMPOUND AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF TRANSPLANT REJECTION

#768
US20240131028A1
Human necessities

CHEMOVACCINATION AGAINST PLASMODIUM INFECTION WITH SELECTIVE PLASMEPSIN X INHIBITORS

#769
US20240131029A1
Human necessities

SELECTIVE ROCK2 INHIBITION FOR TREATMENT OF EDEMA AND ASSOCIATED CONDITIONS

#770
US20240131030A1
Human necessities

METHODS OF TREATING B-CELL PROLIFERATIVE DISORDER

#771 ✅ Patent 12,246,023 granted on 2025-03-11
US20240131031A1
Human necessities

Use of reboxetine to treat narcolepsy

#772
US20240131032A1
Human necessities

AN ACTIVITY-GUIDED MAP OF ELECTROPHILE-CYSTEINE INTERACTIONS IN PRIMARY HUMAN IMMUNE CELLS

#773
US20240131033A1
Human necessities

TREATMENT OF BRAIN INJURIES

#774
US20240131034A1
Human necessities

METHODS OF TREATING STAPHYLOCOCCUS AUREUS BACTEREMIA INFECTIONS

#775
US20240131035A1
Human necessities

AQUEOUS PHARMACEUTICAL FORMULATION OF HYDROCORTISONE SODIUM PHOSPHATE AND MONOTHIOGLYCEROL

#776
US20240131036A1
Human necessities

COMPOSITIONS AND METHODS OF TREATING CONDITIONS

#777
US20240131037A1
Human necessities

MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF

#778
US20240131038A1
Human necessities

ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CANNABIDIOL, DELTA-9-TETRAHYDROCANNABINOL AND LINALOOL

#779
US20240131039A1
Human necessities

TREATMENT OF GASTROINTESTINAL DISORDERS

#780
US20240131040A1
Human necessities

COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS

#781
US20240131041A1
Human necessities

USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CANINE EPILEPSY

#782
US20240131042A1
Human necessities

CANNABIDIOL FOR TREATING NEURODEGENERATIVE DISEASES

#783
US20240131043A1
Human necessities

SPIRAL STEROIDS AND PRECURSORS THEREOF FOR CLINICAL DIAGNOSIS AND TREATMENT OF NECROTIZING ENTEROCOLITIS AND PRE-ECLAMPSIA

#784
US20240131044A1
Human necessities

METHOD FOR TREATING CANCER

#785
US20240131045A1
Human necessities

METHODS FOR TREATMENT OF VIRAL INFECTIONS

#786
US20240131046A1
Human necessities

ANTI-VIRAL AGENT

#787
US20240131047A1
Human necessities

SMALL MOLECULE INHIBITORS OF CD38 AS IMMUNOSUPPRESSANTS

#788
US20240131048A1
Human necessities

MICELLAR NANOPARTICLES AND USES THEREOF

#789
US20240131049A1
Human necessities

CIRCULAR RNA COMPOSITIONS AND METHODS

#790
US20240131050A1
Human necessities

INHIBITION OF EXPANSION AND FUNCTION OF PATHOGENIC AGE-ASSOCIATED B CELLS AND USE FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE DISEASE

#791
US20240131051A1
Human necessities

USE OF MICRORNAS IN THE TREATMENT OF FIBROSIS

#792
US20240131052A1
Human necessities

Anionically Charged Chitosan

#793
US20240131053A1
Human necessities

WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS

#794
US20240131054A1
Human necessities

DOSING REGIMEN FOR NASAL CAVITY AND PHARYNX DECONGESTION

#795
US20240131055A1
Human necessities

METHODS OF OTOPROTECTION AGAINST PLATINUM-BASED ANTINEOPLASTIC AGENTS

#796
US20240131056A1
Human necessities

SODIUM BICARBONATE INJECTABLE FORMULATION AND METHODS THEREOF

#797
US20240131057A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES COMPRISING GERMANIUM TELLURIDE NANOSHEETS COATED WITH POLYVINYLPYRROLIDONE

#798
US20240131058A1
Human necessities

MEDICAL DEVICE FOR THE REPAIR OF A SPINAL OR NERVE LESION, AND SURGICAL METHOD

#799
US20240131059A1
Human necessities

COMPOUNDS FOR IMMUNOMODULATION

#800
US20240131060A1
Human necessities

PATIENT SELECTION FOR TREATMENT WITH DENDRITIC CELL VACCINATION

#801
US20240131061A1
Human necessities

PREPARATION METHOD OF CITRULLINATED VIMENTIN ANTIGEN-SPECIFIC IMMUNE TOLEROGENIC DENDRITIC CELLS, AND USES THEREOF

#802
US20240131062A1
Human necessities

Spray Drying Process That Reduces Pathogens

#803
US20240131063A1
Human necessities

Blood Plasma Product

#804
US20240131064A1
Human necessities

TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH BRAF INHIBITORS AND/OR MEK INHIBITORS

#805
US20240131065A1
Human necessities

CD94 ENGINEERED CELL AND COMPOSITION THEREOF

#806
US20240131066A1
Human necessities

SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING

#807
US20240131067A1
Human necessities

COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS

#808
US20240131068A1
Human necessities

CAR-T CONSTRUCTS COMPRISING A NOVEL CD19 BINDER COMBINED WITH IL18 AND METHODS OF USING THE SAME

#809
US20240131069A1
Human necessities

ADMINISTRATION OF TUMOR INFILTRATING LYMPHOCYTES WITH MEMBRANE BOUND INTERLEUKIN 15 TO TREAT CANCER

#810
US20240131070A1
Human necessities

ANTIGEN RECOGNIZING RECEPTORS TARGETING UPAR AND USES THEREOF

#811
US20240131071A1
Human necessities

LOW INTENSITY ULTRASOUND COMBINATION CANCER THERAPIES

#812
US20240131072A1
Human necessities

ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN

#813
US20240131073A1
Human necessities

MIR200C-EPCAM AXIS REPROGRAMED IMMUNE CELLS FOR ENHANCED ANTI-TUMOR FUNCTION

#814
US20240131074A1
Human necessities

ANTI-PSMA ANTIBODIES AND CAR-T STRUCTURES

#815
US20240131075A1
Human necessities

USE OF MBV FOR TREATING AUTOIMMUNE DISEASE

#816
US20240131076A1
Human necessities

MESENCHYMAL STEM CELL THERAPY OF EPILEPSY AND SEIZURE DISORDERS

#817
US20240131077A1
Human necessities

MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA

#818 ✅ Patent 12,310,992 granted on 2025-05-27
US20240131078A1
Human necessities

Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cells

#819
US20240131079A1
Human necessities

EXTRACELLULAR VESICLES DERIVED FROM INDUCED PLURIPOTENT AND EMBRYONIC STEM CELLS, AND METHODS OF USE FOR IMMUNE MODULATION

#820
US20240131080A1
Human necessities

METHOD FOR REPROGRAMMING HUMAN CELLS

#821
US20240131081A1
Human necessities

OBLIGATE ANAEROBIC HUMAN INTESTINAL MICROBE FOR CANCER TREATMENT, AND USE THEREOF

#822
US20240131082A1
Human necessities

Compositions and Methods for Delivering a Bacterial Metabolite to a Subject

#823
US20240131083A1
Human necessities

COMPOSITIONS COMPRISING ANIMAL HEMOGLOBIN

#824
US20240131084A1
Human necessities

LYOPHILIZED COMPOSITIONS COMPRISING FECAL MICROBE-BASED THERAPEUTIC AGENTS AND METHODS FOR MAKING AND USING SAME

#825
US20240131085A1
Human necessities

LONG-TERM STABLE LIVE FECAL MICROBIOTA COMPOSITION

#826
US20240131086A1
Human necessities

USE OF CLOSTRIDIUM GHONII COMBINED WITH TUMOR ANGIOGENESIS INHIBITOR

#827
US20240131087A1
Human necessities

STRAINS OF LACTOBACILLUS DELBRUECKII WHICH INHIBIT PORPHYROMONAS GINGIVALIS

#828 ✅ Patent 12,246,045 granted on 2025-03-11
US20240131088A1
Human necessities

Method for preparing a transformed, interferon gamma (IFNG)-producing bacterium

#829
US20240131089A1
Human necessities

Composition and Use Thereof

#830
US20240131090A1
Human necessities

PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF GASTROINTESTINAL DISORDERS

#831
US20240131091A1
Human necessities

IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES

#832
US20240131092A1
Human necessities

NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME

#833
US20240131093A1
Human necessities

COMPOSITIONS AND METHODS OF TREATING HUNTINGTON'S DISEASE

#834
US20240131094A1
Human necessities

INFLUENZA VIRUS DEFECTIVE INTERFERING PARTICLES FOR USE IN THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF CORONAVIRIDAE INFECTION

#835
US20240131095A1
Human necessities

ARTIFICIAL ONCOLYTIC VIRUSES AND RELATED METHODS

#836
US20240131096A1
Human necessities

ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY

#837
US20240131097A1
Human necessities

SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT

#838
US20240131098A1
Human necessities

PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD CONTAINING EXTRACT OF FRUITING BODY OF GANODERMA LUCIDUM AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF THROMBOSIS

#839 ✅ Patent 12,220,438 granted on 2025-02-11
US20240131099A1
Human necessities

Protein based cannabis compositions

#840
US20240131100A1
Human necessities

TREATEMENT OF PATHOGEN INFECTIONS FORMULATIONS AND METHODS FOR USE

#841
US20240131101A1
Human necessities

METHOD FOR EXTRACTING AND PURIFYING TOTAL FLAVONOIDS FROM CARTHAMUS TINCTORIUS L. LEAF (TFFCL), AND USE THEREOF

#842
US20240131102A1
Human necessities

FOAM TREATMENT METHOD FOR BACTERIA

#843
US20240131103A1
Human necessities

NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS

#844
US20240131104A1
Human necessities

ORAL BOTANICAL COMPOSITION

#845
US20240131105A1
Human necessities

CHELIDONIUM MAJUS EXTRACTS AND COMPOSITIONS

#846
US20240131106A1
Human necessities

TRADITIONAL CHINESE HERBAL COMPOSITION FOR TREATING PULMONARY NODULE, PREPARATION METHOD THEREOF, AND HONEYED PILL

#847
US20240131107A1
Human necessities

BOTANICAL ANTIVIRAL NUTRITIONAL SUPPLEMENT

#848
US20240131108A1
Human necessities

AMINO ACID-BASED GLASS, PREPARATION METHOD AND USE THEREOF

#849 ✅ Patent 12,350,307 granted on 2025-07-08
US20240131109A1
Human necessities

STABLE ASCORBIC ACID COMPOSITIONS AND METHODS OF USING SAME

#850
US20240131110A1
Human necessities

BONE DISEASE TREATMENT

#851 ✅ Patent 12,257,285 granted on 2025-03-25
US20240131111A1
Human necessities

Composition of BL-8040

#852
US20240131112A1
Human necessities

USE OF METHANOBACTIN FOR TREATMENT OF IRON-RELATED DISEASES

#853
US20240131113A1
Human necessities

PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS

#854
US20240131114A1
Human necessities

NERVE GROWTH FACTOR FUSION PROTEIN, PREPARATION METHOD AND USE THEREOF

#855 ✅ Patent 12,097,244 granted on 2024-09-24
US20240131115A1
Human necessities

Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody

#856
US20240131116A1
Human necessities

METHODS AND THREAPEUTIC COMBINATIONS FOR TREATING IDIOPATHIC INTRACRANIAL HYPERTENSION AND CLUSTER HEADACHES

#857
US20240131117A1
Human necessities

COLLAGENOUS EXTRACTS FOR USE AS A MEDICAMENT

#858
US20240131118A1
Human necessities

CHOLIX TOXIN-DERIVED FUSION MOLECULES FOR ORAL DELIVERY OF BIOLOGICALLY ACTIVE CARGO

#859 ✅ Patent 12,201,678 granted on 2025-01-21
US20240131119A1
Human necessities

Use of pertussis toxin as a therapeutic agent

#860
US20240131120A1
Human necessities

ZIP-IN TECHNOLOGY FOR ANTIVIRAL THERAPEUTIC NANOFORMULATIONS

#861
US20240131121A1
Human necessities

NOVEL OMNI-50 CRISPR NUCLEASE

#862
US20240131122A1
Human necessities

SITE-SPECIFIC CLEAVAGE AND ELIMINATION OF DNA IN BACTERIAL SPECIES WITH SEGMENTED CHROMOSOMES

#863
US20240131123A1
Human necessities

METHODS AND COMPOSITIONS FOR IMPROVING PROTEIN HYDROLYSIS

#864
US20240131124A1
Human necessities

ANTIVIRAL STRUCTURALLY-STABILIZED ACE2 HELIX 1 PEPTIDES AND USES THEREOF

#865
US20240131125A1
Human necessities

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

#866
US20240131126A1
Human necessities

MODIFIED FACTOR IX, AND COMPOSITIONS, METHODS AND USES FOR GENE TRANSFER TO CELLS, ORGANS, AND TISSUES

#867
US20240131127A1
Human necessities

MODIFIED NEUROTOXIN SINGLE-CHAIN POLYPEPTIDE AND USE THEREOF

#868
US20240131128A1
Human necessities

TREATMENT OF CANCER USING BOTULINUM TOXIN AND NITROUS OXIDE

#869
US20240131129A1
Human necessities

VACCINE FOR THERAPEUTIC OR PROPHYLACTIC TREATMENT OF MYASTHENIA GRAVIS

#870
US20240131130A1
Human necessities

COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS

#871
US20240131131A1
Human necessities

AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS

#872
US20240131132A1
Human necessities

ANTIBODIES THAT BIND THE TUMOR (T) ANTIGEN OF MERKEL CELL POLYOMAVIRUS AND RELATED DIAGNOSTICS

#873
US20240131133A1
Human necessities

COMPOSITIONS AND METHODS FOR OPTIMIZED KRAS PEPTIDE VACCINES

#874 ✅ Patent 12,121,575 granted on 2024-10-22
US20240131134A1
Human necessities

Periodontitis vaccine and related compositions and methods of use

#875
US20240131135A1
Human necessities

VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF URINARY TRACT INFECTIONS

#876
US20240131136A1
Human necessities

VACCINE

#877 ✅ Patent 12,233,119 granted on 2025-02-25
US20240131137A1
Human necessities

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

#878
US20240131138A1
Human necessities

CHLAMYDIA VACCINE BASED ON TARGETING MOMP VS4 ANTIGEN TO ANTIGEN PRESENTING CELLS

#879
US20240131139A1
Human necessities

ADJUVANTED SUBCUTANEOUSLY-ADMINISTERED POLYPEPTIDE SARS-COV-2 VACCINES COMPOSITION AND METHODS

#880
US20240131140A1
Human necessities

HPV VACCINE MANUFACTURE

#881 ✅ Patent 12,280,100 granted on 2025-04-22
US20240131141A1
Human necessities

VLP-based bivalent Ebola vaccines and methods of making and using same

#882
US20240131142A1
Human necessities

FLAVIVIRUS VACCINE

#883
US20240131143A1
Human necessities

LASSA VIRUS VACCINE AND USES THEREOF

#884 ✅ Patent 12,208,135 granted on 2025-01-28
US20240131144A1
Human necessities

Formulations of dengue virus vaccine compositions

#885
US20240131145A1
Human necessities

INFLUENZA VACCINE COMPOSITIONS AND METHODS OF USING SAME

#886
US20240131146A1
Human necessities

TETRAVALENT DENGUE INACTIVATED VACCINE

#887
US20240131147A1
Human necessities

POLYPEPTIDES MIMICKING MPER AND V3-LOOP HIV-1 ENV GLYCOPROTEIN EPITOPES

#888
US20240131148A1
Human necessities

IMMUNOGENIC COMPOSITIONS

#889
US20240131149A1
Human necessities

AN ISOLATED POLYPEPTIDE

#890
US20240131150A1
Human necessities

NUCLEIC ACID VACCINES FOR CORONAVIRUS

#891
US20240131151A1
Human necessities

IMMUNOSTIMULATORY COMPOSITIONS

#892 ✅ Patent 12,280,109 granted on 2025-04-22
US20240131152A1
Human necessities

Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines

#893
US20240131153A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF RHEUMATOID ARTHRITIS AND ACCELERATED ATHEROSCLEROSIS

#894
US20240131154A1
Human necessities

COMBINATION OF NOVEL VACCINES AGAINST ZIKA VIRUS AND DNA ANTIBODY CONSTRUCTS FOR USE AGAINST ZIKA VIRUS

#895
US20240131155A1
Human necessities

T CELLS FOR USE IN THERAPY

#896
US20240131156A1
Human necessities

ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF

#897
US20240131157A1
Human necessities

CUSTOMIZED CHIMERIC ANTIGEN RECEPTOR POLYPEPTIDES

#898
US20240131158A1
Human necessities

CELL THERAPY COMPOSITIONS AND METHODS FOR MODULATING TGF-B SIGNALING

#899
US20240131159A1
Human necessities

ERT2 MUTANTS AND USES THEREOF

#900
US20240131160A1
Human necessities

TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES